Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas

ConclusionsWe report actionable targets, including frequentFGFR1 mutation in optic-pathway PA that makes them excellent candidates to anti-FGFR therapies, andBRAF non-canonical mutations in PA.

http://link.springer.com/10.1007/s11060-019-03306-9

Source: Journal of Neuro-Oncology - October 30, 2019 Category: Cancer & Oncology Source Type: research